Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese medicinal composition for treating chloasma

A composition and technology for chloasma, applied in the directions of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problems of unsatisfactory curative effect, easy recurrence, and insignificant curative effect, etc., achieve good therapeutic effect, promote skin metabolism, and regulate endocrine. Effect

Inactive Publication Date: 2012-02-01
黄细刚
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the internal medicines and external medicines used to treat chloasma are mainly vitamins and hormones, and none of them have satisfactory curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Internal medicine:

[0032] 6.5 parts of Angelica, 6 parts of Salvia, 6.5 parts of Bupleurum, 6.5 parts of Poria, 6 parts of Comfrey, 6.5 parts of Alisma, 6.5 parts of winter melon kernel, 6.5 parts of Angelica dahurica, 6.5 parts of Ling Xiaohua, 6.5 parts of rose, 6.5 parts of hibiscus, 6.5 parts of lotus, 6.5 parts of peach blossom, 6.5 parts of bletilla striata, 6.5 parts of Chinese yam, 3.5 parts of safflower, 3.5 parts of licorice;

[0033] External use:

[0034] 20 parts of bletilla striata, 20 parts of angelica dahurica, 10 parts of safflower, 15 parts of salvia miltiorrhiza.

Embodiment 2

[0036] Internal medicine:

[0037] 9.5 parts of Angelica, 9.5 parts of Salvia, 9.5 parts of Bupleurum, 15 parts of Poria, 9 parts of Comfrey, 15 parts of Alisma, 9.5 parts of winter melon kernel, 9.5 parts of Angelica dahurica, 9.5 parts of Lingxiao flower, 9.5 parts of rose, 9.5 parts of hibiscus, 9.5 parts of lotus, 9.5 parts of peach blossom, 9.5 parts of bletilla striata, 15 parts of Chinese yam, 6.5 parts of safflower, 6.5 parts of licorice;

[0038] External use:

[0039] 40 parts of Bletilla striata, 40 parts of Angelica dahurica, 20 parts of safflower, and 30 parts of Danshen.

Embodiment 3

[0041] Internal medicine:

[0042] 8 parts of Angelica, 8 parts of Salvia, 8 parts of Bupleurum, 10.5 parts of Poria, 9 parts of Comfrey, 10.5 parts of Alisma, 8 parts of winter melon kernel, 8 parts of Angelica dahurica, 8 parts of Lingxiao flower, 8 parts of rose, 8 parts of hibiscus; 8 parts of lotus, 8 parts of peach blossom, 8 parts of bletilla striata, 10.5 parts of Chinese yam, 5 parts of safflower, 5 parts of licorice;

[0043] External use:

[0044] 30 parts of Bletilla striata, 30 parts of Angelica dahurica, 15 parts of safflower, and 23 parts of Danshen.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Chinese medicinal composition for treating chloasma. The Chinese medicinal composition comprises an oral medicine and an externally applied medicine. The oral medicine consists of the following powdery Chinese herbal medicines in part by weight: 6.5 to 9.5 parts of Angelica sinensis, 6 to 9.5 parts of root of red-rooted salvia, 6.5 to 9.5 parts of bupleurum chinense, 6.5to 15 parts of tuckahoe, 6 to 9 parts of sinkiang arnebia root, 6.5 to 15 parts of alisma plantagoaquatica, 6.5 to 9.5 parts of wax gourd seed, 6.5 to 9.5 parts of angelica dahurica, 6.5 to 9.5 partsof Chinese trumpet creeper, 6.5 to 9.5 parts of rose, 6.5 to 9.5 parts of hibiscus, 6.5 to 9.5 parts of lotus, 6.5 to 9.5 parts of peach blossom, 6.5 to 9.5 parts of bletilla striata, 6.5 to 15 partsof Chinese yam, 3.5 to 6.5 parts of safflower, and 3.5 to 6.5 parts of liquorice; and the externally applied medicine consists of the lowing Chinese herbal medicines in part by weight: 20 to 40 partsof bletilla striata, 20 to 40 parts of angelica dahurica, 10 to 20 parts of safflower, and 15 to 30 parts of root of red-rooted salvia. The invention has the advantages that: chloasma is treated by combining the oral medicine and the externally applied medicine, and the Chinese medicinal composition has a better treatment effect than a single medicine.

Description

technical field [0001] The invention belongs to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating chloasma. Background technique [0002] Chloasma disease is a common multiple disease, which occurs in facial pigmentation disease, which affects the appearance very much, especially in women, and more than 70% of the population in my country suffers from it. The onset is related to internal injuries of the seven emotions, stagnation of liver qi, fatigue from diet, liver and kidney deficiency, and irregular menstrual blood in women. At present, the internal medicines and external medicines used to treat chloasma are mainly vitamins and hormones, and none of them have satisfactory curative effects. Some of them are effective during the medication period, and they are prone to relapse after stopping the medication, and some of them have no significant curative effect, etc. . Contents of the invention [0003] T...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/898A61P17/00
Inventor 龚杨宇黄细刚
Owner 黄细刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products